HIF1A and colorectal cancer: Taken together, these results verified that AAM effectively inhibits migration and VM formation by suppressing the ROS/HIF-1α/MMP2 pathway in colorectal cancer under hypoxic condition, suggesting AAM could serve as a therapeutic agent to inhibit VM formation in human colorectal cancer.